-
New study: Workplace bullying increases risk of heart disease.
Time of Update: 2020-08-19
Proper expression of concern and goodwill is also important, leaders should pay more attention to the work and life of subordinates, business ability should also try to help colleagues solve problems, friendly cooperation.
-
Beijing Anzhen Hospital is the only designated high-risk pregnant woman for heart disease.
Time of Update: 2020-08-19
"It is recommended that pregnant women with combined heart disease go to a specialist hospital for a detailed pre-pregnancy assessment, under the guidance of a doctor to a qualified hospital to monitor pregnancy, to reduce maternal risk." (Combined from Beijing Youth Daily, Health Times) .
-
How did district toothache develop into a heart attack?
Time of Update: 2020-08-19
Reporters yesterday from Zhongshan University Sun Yat-sen Memorial Hospital dental department was informed that a 32-year-old man in Guangzhou recently toothache for several weeks pain not to treat, and finally developed into endocarditis, nearly died.
-
A heart attack is more deadly in winter! The mortality rate is as high as 28%.
Time of Update: 2020-08-19
researchers say the high winter heart attack death synodles are likely to include extended treatment, longer hospital stays, and an increase in infections from related diseases, risk factors that can be fatal in the most severely ill patients.
-
Heart attack symptoms are different for men and women! FDA gives women heart health advice.
Time of Update: 2020-08-18
heart disease can lead to serious or fatal health problems, such as a heart attack or stroke, but steps can be taken to reduce the risk of problems.
Diabetes, high blood pressure and high cholesterol increase the risk of heart disease.
-
Six signals to warn you of a heart attack!
Time of Update: 2020-08-18
doctors recommend that patients with blepharomas must be seen, and check the corresponding blood lipid indicators to assess the risk of long-term cardiovascular disease, while maintaining a healthy lifestyle, control blood lipids and blood pressure and other risk factors for coronary heart disease.
-
NEJM: The risk of heart disease in the first week of influenza is six times higher than usual.
Time of Update: 2020-08-18
A study published this week in the New England Journal of Medicine (NEJM) shows that flu significantly increases the risk of heart attack, especially in the first week of flu, six times as often.
-
27% lower risk of heart disease! The new amsin cardiovascular drug was approved by the FDA.
Time of Update: 2020-08-18
Amgen recently announced that the U.S. Food and Drug Administration (FDA) has approved the company's repatha ® supplemental biologics licensing application (sBLA) as the first PCSK9 inhibitor to prevent heart disease and cardiovascular disease, stroke and coronary artery blood transport to rebuild adults.
Doctors now have a new FDA-approved treatment to prevent cardiovascular events by significantly lowering LDL cholesterol levels.
-
WHO: Less than 10% insaturated fatty acids reduces the risk of heart disease.
Time of Update: 2020-08-18
The World Health Organization recently suggested that no more than 10% of the calories consumed by adults and children ( such as meat and butter ) and no more than 1% of trans fatty acids can reduce the risk of heart disease .
-
JACC: Revealing the mystery that biostents increase the risk of heart attack.
Time of Update: 2020-08-18
However, most recent studies on stents have shown that biostents cause significantly more complications than usual metal stents, especially more than a year after stent implantation.
"As a direct consequence of these findings, we recommend that our patients who receive biostent implants continue to take two blood thinners.
-
NEJM: Slug ulcer - case report.
Time of Update: 2020-08-06
The patient was a 50-year-old woman who went to a dermatology clinic because of painless ulcers in her upper jaw and swelling of her lips, which was associated with intermittent fever and general discomfort.
-
Blood: Induced acquired FXIII-B lacks sustainable reduction of FXIII-A.
Time of Update: 2020-08-06
FxIII-A, the activated form of the coagulation factor XIII (FXIII-A2B2), is a hemostatic enzyme that inhibits fibrin dissolution by irreversibly cross-linking fibrillin and anti-fibre-soluble protein.
in vitro, the cross-linking of alpha2-anti-fisolysozyme and fibrin is impaired and the fiscota is enhanced.
-
1 the process of producing weak antibodies in multiple blood transfusions and their effect on the effect of blood transfusion.
Time of Update: 2020-08-06
the use of enzyme-MGT, patient direct resistance to yin, 37 degrees C temperature control cold antibody interference, the use of a variety of anti-human globulin gel card to detect plasma, with higher sensitivity and intuitive results, for the identification of weak IgM type irregular antibodies provides an optional method.
-
A selection of Blood research highlights from July 30, 2020.
Time of Update: 2020-08-06
a new method for predicting the survival rate of allo-HCT in sickle cell patients at https://doi.org/10.1182/blood.2020005687 Researchers recently developed a risk score to predict the event-free survival rate (EFS; the study population (n-1425) was randomly divided into training groups (n-1070) and validation groups (n-355).
-
Nature: Single-cell lineage tracking has found important functions of TCF5 in hematopoietic action.
Time of Update: 2020-08-06
Klein, published a study in Nature, "Single-cell lineage tracing unveils a row for TCF15 in haemapois", using the DNA barcode library to reveal the intrinsic molecular characteristics of HSCs with different regenerative capabilities, and identified the importance of transcription factor TCF5 to maintain hCs.
-
Blood: Hydrogen-thorium exchange mass spectrometry studies the conformational changes of FVIII-driven FIXa.
Time of Update: 2020-08-06
The assembly of the enzyme-activated factor IX (FIXa) and its cofactor activated VIII factor (FVIIIa) is a key event in the clotting cascade reaction.
in the changes that are driven by cofactors and substrates, HDX-MS highlights several surface rings associated with the structural network of the associated clotting enzymes.
-
Blood: Platelet activation and platelet-mononucleosis in patients with severe COVID-19 form trigger tissue factor expression.
Time of Update: 2020-08-04
in general, the study data highlighted a new pathogenic mechanism involving platelet activation and platelet-dependent mononucleosis, which is associated with the severity and mortality of COVID-19.
-
JCO:CAR-T is used for real-world data release of recurrent or refractable large B-cell lymphoma, with consistent results with the results of the trial.
Time of Update: 2020-08-01
. Car-T products from Gilead/Kite, Yescarta (Axicabagene Cilleucel, Axi-Cel), were approved by the FDA in the fall of 2017 based on the results of its single-arm Phase II clinical trial ZUMA-1 for treatment in adult patients with recurrent or refractive large B cell lymphoma (LBCL).
-
NEJM: CAR-NK cell therapy works brightly in blood tumors!
Time of Update: 2020-08-01
Studies have shown that most patients who treated patients with recurrent or refractive non-Hodgkin's lymphoma (NHL) and chronic lymphocytic leukemia (CLL) with CAR-NK therapy, a source of cord blood, with extensive treatment, developed a clinical response withno major toxic effects.
-
1 case of combined heptopha cytopha syndrome during pregnancy.
Time of Update: 2020-08-01
LDH?triceratlygine is significantly elevated, the bone marrow has macrophages and other manifestations, patients with blood cell syndrome diagnosis is clear, but sustained high fever for more than 2 weeks, the cause is still unclear, infection has not been ruled out?
